{"id":"https://openalex.org/W7204556220","doi":"https://doi.org/10.21037/jgo-2026-0657","title":"Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial","display_name":"Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204556220","doi":"https://doi.org/10.21037/jgo-2026-0657","pmid":"https://pubmed.ncbi.nlm.nih.gov/42703466","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13546580"},"language":"en","primary_location":{"id":"doi:10.21037/jgo-2026-0657","doi":"https://doi.org/10.21037/jgo-2026-0657","is_oa":true,"landing_page_url":"https://doi.org/10.21037/jgo-2026-0657","pdf_url":null,"source":{"id":"https://openalex.org/S2764940779","display_name":"Journal of Gastrointestinal Oncology","issn_l":"2078-6891","issn":["2078-6891","2219-679X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Gastrointestinal Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21037/jgo-2026-0657","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058408659","display_name":"Furong Kou","orcid":"https://orcid.org/0000-0002-8969-6344","observed_orcids":["https://orcid.org/0000-0002-8969-6344"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Furong Kou","raw_affiliation_strings":["Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Comprehensive Clinical Trial Ward, Peking University Cancer Hospital & Institute, Beijing, China","Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Comprehensive Clinical Trial Ward, Peking University Cancer Hospital & Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]},{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087215545","display_name":"Xicheng Wang","orcid":"https://orcid.org/0000-0001-6073-2869","observed_orcids":["https://orcid.org/0000-0001-6073-2869"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xicheng Wang","raw_affiliation_strings":["Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100402533","display_name":"Jian Li","orcid":"https://orcid.org/0000-0002-7076-3332","observed_orcids":["https://orcid.org/0000-0002-7076-3332"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jian Li","raw_affiliation_strings":["Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065755796","display_name":"Zhenghang Wang","orcid":"https://orcid.org/0000-0001-8307-693X","observed_orcids":["https://orcid.org/0000-0001-8307-693X","https://orcid.org/0009-0004-4166-576X"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhenghang Wang","raw_affiliation_strings":["Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5137181816","display_name":"Ting Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ting Xu","raw_affiliation_strings":["Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5137181816"],"corresponding_institution_ids":["https://openalex.org/I4210093964"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"4","first_page":"245","last_page":"245"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8899999856948853},{"id":"https://openalex.org/keywords/raltitrexed","display_name":"raltitrexed","score":0.8989999890327454},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5950000286102295},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6959999799728394},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9480000138282776},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.843999981880188},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.8320000171661377},{"id":"https://openalex.org/keywords/ras-wild-type","display_name":"RAS wild-type","score":0.6430000066757202},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.9350000023841858},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.550000011920929},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9715999960899353},{"id":"https://openalex.org/C2779268555","wikidata":"https://www.wikidata.org/wiki/Q15304877","display_name":"Raltitrexed","level":5,"score":0.928600013256073},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8108000159263611},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7709000110626221},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.705299973487854},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.70169997215271},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.6209999918937683},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6176999807357788},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.39579999446868896},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35830000042915344},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35659998655319214},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.33390000462532043},{"id":"https://openalex.org/C2775965419","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter trial","level":4,"score":0.31790000200271606},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.3147999942302704},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2987000048160553},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28870001435279846},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.2815999984741211},{"id":"https://openalex.org/C2776055544","wikidata":"https://www.wikidata.org/wiki/Q3877039","display_name":"Nimotuzumab","level":4,"score":0.27880001068115234},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.2761000096797943},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.2711000144481659},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.26989999413490295},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.25850000977516174},{"id":"https://openalex.org/C2781074409","wikidata":"https://www.wikidata.org/wiki/Q158716","display_name":"Rectum","level":2,"score":0.2554999887943268},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2515000104904175}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.21037/jgo-2026-0657","doi":"https://doi.org/10.21037/jgo-2026-0657","is_oa":true,"landing_page_url":"https://doi.org/10.21037/jgo-2026-0657","pdf_url":null,"source":{"id":"https://openalex.org/S2764940779","display_name":"Journal of Gastrointestinal Oncology","issn_l":"2078-6891","issn":["2078-6891","2219-679X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Gastrointestinal Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13546580","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13546580/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13546580/pdf/jgo-17-04-245.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Gastrointest Oncol","raw_type":"Text"},{"id":"pmid:42703466","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42703466","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of gastrointestinal oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21037/jgo-2026-0657","doi":"https://doi.org/10.21037/jgo-2026-0657","is_oa":true,"landing_page_url":"https://doi.org/10.21037/jgo-2026-0657","pdf_url":null,"source":{"id":"https://openalex.org/S2764940779","display_name":"Journal of Gastrointestinal Oncology","issn_l":"2078-6891","issn":["2078-6891","2219-679X"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321814","host_organization_name":"AME Publishing Company","host_organization_lineage":["https://openalex.org/P4310321814"],"host_organization_lineage_names":["AME Publishing Company"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Gastrointestinal Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204556220.pdf","grobid_xml":"https://content.openalex.org/works/W7204556220.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W2102601598","https://openalex.org/W2110519215","https://openalex.org/W2125447919","https://openalex.org/W2133399075","https://openalex.org/W2142564546","https://openalex.org/W2156700619","https://openalex.org/W2543412381","https://openalex.org/W2605964154","https://openalex.org/W3035123198","https://openalex.org/W3109078561","https://openalex.org/W3110528877","https://openalex.org/W3134887329","https://openalex.org/W4211247697","https://openalex.org/W4221063971","https://openalex.org/W4283382258","https://openalex.org/W4315754639","https://openalex.org/W4400413703","https://openalex.org/W4402138678","https://openalex.org/W4408066017","https://openalex.org/W7124246947"],"related_works":["https://openalex.org/W4402574573","https://openalex.org/W4400413703","https://openalex.org/W2990044624","https://openalex.org/W4225286439","https://openalex.org/W2591269939","https://openalex.org/W2065160200","https://openalex.org/W4233337148","https://openalex.org/W2397841699","https://openalex.org/W2590751417","https://openalex.org/W2590436920"],"abstract_inverted_index":{"Background:":[0],"The":[1,122,175,318],"prospective":[2,300],"multicenter":[3,301],"SALLY":[4,52,72],"registry":[5],"reported":[6],"that":[7],"raltitrexed":[8],"plus":[9],"irinotecan":[10],"(SALIRI)-based":[11],"regimens":[12],"can":[13],"be":[14,329],"used":[15],"as":[16,313],"second-line":[17,60,314],"treatment":[18,335],"for":[19,316],"metastatic":[20,160],"colorectal":[21],"cancer":[22],"(mCRC).":[23],"Outcomes":[24],"according":[25],"to":[26,345],"the":[27,51,71,198,323,347],"addition":[28],"of":[29,50,298,333,351],"bevacizumab":[30],"(Bev),":[31],"cetuximab":[32],"(Cet),":[33],"or":[34,67,185,268,307],"no":[35],"targeted":[36],"agents":[37],"are":[38,343],"less":[39],"clear":[40],"in":[41,81,146,164,197,264,322],"routine":[42,82],"practice.":[43],"We":[44,55],"performed":[45],"an":[46],"exploratory":[47],"secondary":[48,296],"analysis":[49,123,297],"registry.":[53],"Methods:":[54],"included":[56,124,180],"patients":[57,84,182],"who":[58],"received":[59,128,133,139],"SALIRI":[61,64,68,129,134,140,176,199,207,209,233,244,253,257,288,303,324],"+":[62,65,130,135,177,200,210,234,254,258,289,325],"Bev,":[63,131],"Cet,":[66,136],"alone":[69],"from":[70],"full":[73],"analytical":[74],"set.":[75],"Treatment":[76],"was":[77,212,284,309],"selected":[78],"by":[79],"physicians":[80],"care;":[83],"were":[85,104,117,143,194,249,275],"not":[86,250,261],"randomized.":[87],"Tumor":[88],"response,":[89],"progression-free":[90],"survival":[91,94],"(PFS),":[92],"overall":[93],"(OS),":[95],"disease":[96],"control":[97],"rate":[98,219],"(DCR),":[99],"and":[100,107,114,137,159,169,188,202,225,241,256,277,311,340],"treatment-related":[101,272],"adverse":[102,273],"events":[103,274],"compared":[105],"descriptively":[106],"with":[108,183,206,214,287,305],"unadjusted":[109],"statistical":[110],"tests.":[111],"Baseline":[112],"clinicopathologic":[113],"molecular":[115,170],"characteristics":[116],"assessed":[118],"across":[119,280],"groups.":[120,204],"Results:":[121],"1,049":[125],"patients:":[126],"678":[127],"103":[132],"268":[138],"alone.":[141],"Groups":[142],"broadly":[144],"similar":[145,279],"sex,":[147],"Eastern":[148],"Cooperative":[149],"Oncology":[150],"Group":[151],"(ECOG)":[152],"performance":[153],"status,":[154,158],"pathological":[155],"type,":[156],"resection":[157],"burden,":[161],"but":[162,246],"differed":[163],"age,":[165],"primary":[166],"tumor":[167],"location,":[168],"profile":[171],"among":[172],"tested":[173],"patients.":[174],"Cet":[178,211,255,308,326],"group":[179],"more":[181,285],"left-sided":[184],"rectal":[186],"tumors":[187,193],"RAS":[189],"wild-type":[190],"disease.":[191],"BRAF-mutant":[192],"found":[195],"only":[196],"Bev":[201,235,259,306],"SALIRI-alone":[203],"Compared":[205],"alone,":[208,245],"associated":[213],"a":[215,299],"higher":[216,238],"objective":[217],"response":[218],"(ORR)":[220],"(27.2%":[221],"vs.":[222,229],"15.7%;":[223],"P=0.02)":[224],"longer":[226],"OS":[227],"(19.9":[228],"17.0":[230],"months;":[231],"P=0.006).":[232],"showed":[236],"numerically":[237],"ORR,":[239,265],"DCR,":[240,266],"PFS":[242],"than":[243],"these":[247],"differences":[248],"statistically":[251],"significant.":[252],"did":[260],"differ":[262],"significantly":[263],"PFS,":[267],"OS.":[269],"Grade":[270],"3\u20134":[271],"infrequent":[276],"generally":[278],"groups,":[281],"although":[282],"rash":[283],"common":[286],"Cet.":[290],"Conclusions:":[291],"In":[292],"this":[293],"exploratory,":[294],"nonrandomized":[295],"registry,":[302],"combined":[304],"feasible":[310],"tolerable":[312],"therapy":[315],"mCRC.":[317],"observed":[319],"favorable":[320],"outcomes":[321],"subgroup":[327],"should":[328],"interpreted":[330],"cautiously":[331],"because":[332],"nonrandom":[334],"allocation.":[336],"Future":[337],"prospective,":[338],"biomarker-driven":[339],"randomized":[341],"studies":[342],"warranted":[344],"define":[346],"optimal":[348],"clinical":[349],"positioning":[350],"SALIRI-based":[352],"combinations.":[353]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-29T00:00:00"}